John Vandermosten

Stock Analyst at Zacks Investment Research

(0.04)
# 4,307
Out of 4,884 analysts
1
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by John Vandermosten

Tiziana Life Sciences
Apr 12, 2021
Initiates: Not Rated
Price Target: $7.5
Current: $1.51
Upside: +396.69%